Product Description
Pill Cat FIPV Treatment GS Pill 17mg 32mg
Introduction:
is a competitive inhibitor of nucleoside triphosphate. It can inhibit the replication of several different types of RNA, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome, Ebola, Lassa fever, Junin and respiratory syncytium, etc., and has low cytotoxicity in a wide range of cell lines.
Function:
is phosphorylated to nucleoside monophosphate (NMP) by cell kinase, and then transformed into an active triphosphate metabolite (NTP structural analogue). In RNA synthesis, active NTP structure analogues act as natural nucleoside triphosphate competitors and compete with natural nucleosides (ATP, TTP, CTP, GTP) to participate in RNA transcription. When is inserted into the transcripts, transcription will be terminated early, thus inhibiting the RNA transcription process.
1. The effect of fever 12-36 subsided
2. Ascites subside within 1-2 weeks after medication
3. Significant improvement in spirit, take the initiative to eat
4. Difficulty breathing, pleural effusion symptoms subside within 1-2 weeks
5. Jaundice will subside in 2-4 weeks Precautions
1. The nutrient solution (inhibitor) is still in the experimental stage, and individual animals are purely different. The specific effects vary depending on the individual's immunity.
2. After injection, the injection site may be more painful, and the pain lasts for 0.2-2 hours.
3. Improper injection may cause skin ulceration and subcutaneous swelling. It is necessary to confirm that there is no leakage during subcutaneous injection to avoid skin damage.
Audited Supplier 
){kind=link}